These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32327367)

  • 21. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
    Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
    Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
    Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
    Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Luchini C; Mino-Kenudson M; Paiella S; Qadan M; Scarpa A; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
    Ann Surg Oncol; 2020 Oct; 27(10):3898-3912. PubMed ID: 32307617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review.
    Uijterwijk BA; Lemmers DH; Fusai GK; Zerbi A; Salvia R; Sparrelid E; White S; Björnsson B; Mavroeidis VK; Roberts KJ; Mazzola M; Cabús SS; Soonawalla Z; Korkolis D; Serradilla M; Pessaux P; Luyer M; Mowbray N; Ielpo B; Mazzotta A; Kleeff J; Boggi U; Muñoz MAS; Goh BKP; Andreotti E; Wilmink H; Ghidini M; Zaniboni A; Verbeke C; Adsay V; Bianchi D; Besselink MG; Abu Hilal M;
    Ann Surg Oncol; 2024 Jul; 31(7):4654-4664. PubMed ID: 38602578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the optimal surgical approach for ductal adenocarcinoma of the pancreatic neck? - a retrospective cohort study.
    Rompen IF; Habib JR; Sereni E; Stoop TF; Musa J; Cohen SM; Berman RS; Kaplan B; Hewitt DB; Sacks GD; Wolfgang CL; Javed AA
    Langenbecks Arch Surg; 2024 Jul; 409(1):224. PubMed ID: 39028426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.
    Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
    World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
    Konstantinidis IT; Deshpande V; Zheng H; Wargo JA; Fernandez-del Castillo C; Thayer SP; Androutsopoulos V; Lauwers GY; Warshaw AL; Ferrone CR
    J Gastrointest Surg; 2010 Feb; 14(2):261-7. PubMed ID: 19937477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic ductal adenocarcinoma (PDAC) regional nodal disease at standard lymphadenectomy: is MRI accurate for identifying node-positive patients?
    Adham S; Ferri M; Lee SY; Larocque N; Alwahbi OA; Ruo L; van der Pol CB
    Eur Radiol; 2023 Sep; 33(9):5976-5983. PubMed ID: 37004569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM.
    Marchegiani G; Andrianello S; Malleo G; De Gregorio L; Scarpa A; Mino-Kenudson M; Maggino L; Ferrone CR; Lillemoe KD; Bassi C; Castillo CF; Salvia R
    Ann Surg; 2017 Jul; 266(1):142-148. PubMed ID: 27322188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
    Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
    J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
    Wang W; Shen Z; Zhang J; Chen H; Deng X; Peng C; Xie J; Xu Z; Shen B
    Ann Surg Oncol; 2022 Mar; 29(3):1533-1539. PubMed ID: 34622372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.
    Ashfaq A; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
    J Gastrointest Surg; 2014 Nov; 18(11):1929-35. PubMed ID: 24916590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.
    Curran T; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
    J Gastrointest Surg; 2015 Jan; 19(1):152-60; discussion 160. PubMed ID: 25118642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
    Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
    JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
    Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
    Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.